Joinn Laboratories (China) Co Ltd
Company Profile
Business description
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Contact
A5 Rongjing East Street
Beijing Economic-Technological Development Area
Beijing100176
CHNT: +86 1067869966
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
2,652
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,341.00 | 53.10 | 0.64% |
CAC 40 | 7,542.48 | 13.39 | -0.18% |
DAX 40 | 22,324.29 | 101.54 | -0.45% |
Dow JONES (US) | 39,923.97 | 603.65 | -1.49% |
FTSE 100 | 8,448.40 | 15.06 | -0.18% |
HKSE | 22,119.41 | 111.30 | 0.51% |
NASDAQ | 17,083.02 | 378.29 | -2.17% |
Nikkei 225 | 36,045.38 | 205.39 | 0.57% |
NZX 50 Index | 11,903.31 | 122.14 | -1.02% |
S&P 500 | 5,464.33 | 96.50 | -1.74% |
S&P/ASX 200 | 8,126.20 | 55.60 | 0.69% |
SSE Composite Index | 3,279.03 | 7.62 | -0.23% |